Comparing two antibiotics for brain infections
Treatments studied
Part of Brain & nervous system, Infections clinical trials.
This trial tests two strong antibiotics, tigecycline and colistimethate, to see which works better for serious brain or spinal infections in children. It might help if your child has an infection in the fluid around the brain and needs a special drain to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 month and 18 years old.
- They must have symptoms of a brain or spinal infection, like fever, confusion, or abnormal spinal fluid test results.
- They must have a tube (called an EVD) placed to drain fluid from the brain and treat the infection.
- Your child cannot have a known allergy to either tigecycline or colistimethate.
- They cannot have other serious medical conditions that would affect the study results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether washing out the infected fluid spaces in the brain (ventricular irrigation) can safely treat a serious brain infection (ventriculitis). It is for adults with a confirmed infection and fever who are stable enough for the procedure.
This trial focuses on people in Denmark who may have an infection in the brain or the fluid around the brain and spinal cord. Researchers aim to collect and compare diagnostic results for different infection types (viral meningitis, bacterial meningitis, encephalitis, and others) to help confirm the cause and guide care.
This trial is for adults with a serious brain infection caused by drug-resistant bacteria. It tests giving an antibiotic (polymyxin B) directly into the brain through a drain tube to see if it works better.
This study tests two different pairs of strong antibiotics to see which works better at clearing hard-to-treat bacterial infections that don't respond to standard drugs. You would receive one of these two combinations and be monitored for how well it works and any side effects.
This trial tests if adding antibiotics directly into the skull bone marrow, along with standard IV antibiotics, helps people with moderate-to-severe bacterial meningitis who are not getting better after 2-3 days of regular treatment.
This trial tests whether adding the antibiotic doxycycline to standard treatment can improve recovery in patients with tuberculosis of the brain (TB meningitis). It may help reduce brain swelling and damage.
Hear when a new Central Nervous System Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.